Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings
Recruiting
Phase 4
Interventional Study
Suspect Renal and Adrenal Imaging Findings
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 104 (estimated)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to compare the effects of the contrast agent Gadopiclenol with those of the standard contrast agent Gadobutrol.
The main question of this study is :
Does gadopiclenol offer diagnostic properties that are equally effective as those of gadobutrol?
Participants will be:
* randomly assigned to one of two groups: the experimental group, which receives gadopiclenol, or t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* signed informed consent
* age ≥18 years
* compatibility with magnetic resonance imaging
* planned workup of kidney incidental finding or adrenal incidental findings (or both)
* body mass index (BMI) \< 31 kg/m2
Exclusion Criteria:
* patients with implants that might affect i…
Contacts